Saturday 17 October 2026 Export BIO’s income statement to Excel — free account

Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.6 billion, up 0.65% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS grew 19.0%, free cash flow fell 6.06% and total debt was flat, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.

353.70 11.12 −3.05%

Follow BIO

Alert me

Market cap: $9.8B
P/E: 42.5×
Fwd P/E: 35.4×
Dividend yield: —
F-score: 5/9
Altman Z: 3.20
Beneish M: −2.29
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	35.25	45.62	10.84	0.00	+8 more quarters Free account
P/S ratio Full definition →	3.03	2.90	3.20	2.95
P/FCF ratio Full definition →	22.11	20.91	21.93	22.27
P/Operating CF Full definition →	79.56	69.51	50.09	62.44
P/B ratio Full definition →	1.09	1.10	1.11	1.12
Price to Tangible BV Full definition →	1.22	1.23	1.23	1.31
EV/Sales Full definition →	2.87	2.76	3.07	2.87
EV/EBITDA Full definition →	140.08	124.19	167.85	32.66
EV/Operating CF Full definition →	15.10	14.02	14.89	14.92
EV/FCF Full definition →	20.95	19.90	21.03	21.64
Quick Ratio Full definition →	2.14	2.17	3.87	3.61
Current Ratio Full definition →	3.14	3.21	5.62	5.44
Net Debt/EBITDA Full definition →	(5.71)	(10.60)	2.84	(3.31)
Debt/Assets Full definition →	11.74%	12.29%	11.37%	12.40%
Debt/Equity Full definition →	0.17	0.18	0.16	0.18
Asset Turnover Full definition →	0.25	0.27	0.26	0.25
Operating CF/Net income Full definition →	0.27	(0.21)	0.23	(0.35)
Capex/Depreciation Full definition →	0.00	0.00	(0.28)	0.00
Interest Coverage Full definition →	6.00	2.77	(9.83)	5.31
Research and Development Expense of Revenue Full definition →	9.40%	0.00%	0.00%	10.92%
Selling, General and Administrative Expense of Revenue Full definition →	32.57%	35.87%	31.88%	31.67%
Intangible Assets out of Total Assets Full definition →	0.07	0.08	0.07	0.10
Share Based Compensation of Revenue Full definition →	0.00%	0.00%	8.37%	0.00%
Graham Net Nets Full definition →	(0.01)	0.00	(0.03)	(0.02)
Graham Number Full definition →	224.21	186.92	414.65	0.00
Earnings Yield Full definition →	2.84%	2.19%	9.22%	(8.67%)
Free Cash Flow Yield Full definition →	4.52%	4.78%	4.56%	4.49%
Revenue per Share Full definition →	24.34	21.96	25.43	24.25
Operating CF per Share Full definition →	3.69	4.01	6.05	4.49
Capex per Share Full definition →	(1.20)	(1.11)	(1.68)	(1.18)
Free Cash Flow per Share Full definition →	2.49	2.90	4.37	3.31
Cash per Share Full definition →	60.51	58.04	56.51	52.69
Shareholders Equity per Share Full definition →	268.22	254.15	273.40	250.22
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	268.22	254.15	273.40	250.22
Free Cash Flow Full definition →	66.60	78.20	119.10	89.20
Working Capital Full definition →	2,059.20	2,025.10	2,389.20	2,319.70
Capital Expenditures Full definition →	(32.10)	(29.90)	(45.80)	(31.70)
Net Current Asset Value Full definition →	(57.60)	3.40	(216.70)	(117.60)
EV/EBIT Full definition →	140.08	124.19	167.85	32.66
Capex to Sales Full definition →	0.05	0.05	0.07	0.05
Price to Operating Income Full definition →	147.89	130.46	175.01	33.63
Other line items
Average Receivables Full definition →	455.85	425.45	456.55	463.32
Average Payables Full definition →	141.40	135.50	125.65	125.49
Average Inventory Full definition →	789.70	780.30	750.35	793.74
Average Assets Full definition →	10,233.05	9,658.45	9,970.30	10,149.94
Average Common Equity Full definition →	7,151.30	6,765.35	7,011.45	7,112.33

Fold the line items

Columns are period end dates

Stockrow Weekly